Retinal microglia are activated by systemic fungal infection

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 6, 2014, Pages 3578-3585

  Maneu, Victoria ^a,b   Noailles, Agustina ^a   Megías, Javier ^c   Gómez Vicente, Violeta ^a   Carpena, Núria ^c   Luisa Gil, M ^c   Gozalbo, Daniel ^c   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b INSTITUTO TEÓFILO HERNANDO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Candidiasis; Infection; Microglial activation; Retina

Indexed keywords

CD11B ANTIBODY; CD45 ANTIBODY; IBA 1 ANTIBODY; MHCII ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; SYSTEMIC MYCOSIS;

CANDIDIASIS; INFECTION; MICROGLIAL ACTIVATION; RETINA;

ANIMALS; AXONAL TRANSPORT; CANDIDIASIS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, CONFOCAL; RETINAL DEGENERATION; RETINAL GANGLION CELLS;

EID: 84902531794     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14051     Document Type: Article

References (48)

1. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology. 2010;215:685-691.
2. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
3. Polazzi E, Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol. 2010;92:293-315.
4. Harry GJ. Microglia during development and aging. Pharmacol Ther. 2013;139:313-326.
5. Czeh M, Gressens P, Kaindl AM. The yin and yang of microglia. Dev Neurosci. 2011;33:199-209.
6. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol. 1992;263:C1-C16.
7. Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64: 110-122.
8. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 2009;8:382-397.
9. Tansey MG, McCoy MK, Frank-Cannon TC. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol. 2007;208:1-25.
10. Bornemann KD, Wiederhold KH, Pauli C, et al. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol. 2001;158:63-73.
11. Griffin WS, Liu L, Li Y, Mrak RE, Barger SW. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006;3:5.
12. Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and agerelated macular degeneration. Exp Eye Res. 2003;76:463-471.
13. Ardeljan D, Chan CC. Aging is not a disease: distinguishing agerelated macular degeneration from aging. Prog Retin Eye Res. 2013;37:68-89.
14. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385-414.
15. Bosco A, Crish SD, Steele MR, et al. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One. 2012;7:e43602.
16. Gallego BI, Salazar JJ, de Hoz R, et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation. 2012;9:92.
17. Lionakis MS, Lim JK, Lee CC, Murphy PM. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun. 2011;3:180-199.
18. Yanez A, Murciano C, O'Connor JE, Gozalbo D, Gil ML. Candida albicans triggers proliferation and differentiation of hematopoietic stem and progenitor cells by a MyD88-dependent signaling. Microbes Infect. 2009;11:531-535.
19. Murciano C, Yanez A, Gil ML, Gozalbo D. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling. Eur Cytokine Netw. 2007;18:38-43.
20. Villamon E, Gozalbo D, Roig P, O'Connor JE, Fradelizi D, Gil ML. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect. 2004;6:1-7.
21. Murciano C, Villamon E, Gozalbo D, Roig P, O'Connor JE, Gil ML. Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol. 2006;44:149-157.
22. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun. 1996;224:855-862.
23. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1-9.
24. Dick AD, Ford AL, Forrester JV, Sedgwick JD. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/ c{thorn}CD4low parenchymal microglia. Br J Ophthalmol. 1995;79: 834-840.
25. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol. 2004;75:388-397.
26. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312-318.
27. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A. 1991;88:7438-7442.
28. Zinkernagel MS, Chinnery HR, Ong ML, et al. Interferon gamma-dependent migration of microglial cells in the retina after systemic cytomegalovirus infection. Am J Pathol. 2013; 182:875-885.
29. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci. 2011; 14:1142-1149.
30. Sasahara M, Otani A, Oishi A, et al. Activation of bone marrowderived microglia promotes photoreceptor survival in inherited retinal degeneration. Am J Pathol. 2008;172:1693-1703.
31. Joly S, Francke M, Ulbricht E, et al. Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol. 2009;174: 2310-2323.
32. Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest. 2006;116:3266-3276.
33. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron. 2006; 49:489-502.
34. Kezic J, Xu H, Chinnery HR, Murphy CC, McMenamin PG. Retinal microglia and uveal tract dendritic cells and macrophages are not CX3CR1 dependent in their recruitment and distribution in the young mouse eye. Invest Ophthalmol Vis Sci. 2008;49:1599-1608.
35. Xu H, Chen M, Mayer EJ, Forrester JV, Dick AD. Turnover of resident retinal microglia in the normal adult mouse. Glia. 2007;55:1189-1198.
36. Kaneko H, Nishiguchi KM, Nakamura M, Kachi S, Terasaki H. Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci. 2008; 49:4162-4168.
37. Graeber MB, Streit WJ. Microglia: biology and pathology. Acta Neuropathol. 2010;119:89-105.
38. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009;27: 119-145.
39. Gregerson DS, Yang J. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFNgamma or anti-CD40. Invest Ophthalmol Vis Sci. 2003;44: 3083-3093.
40. Held J, Kohlberger I, Rappold E, Busse Grawitz A, Hacker G. Comparison of (1->3)-beta-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol. 2013;51:1158-1164.
41. Gil ML, Gozalbo D. Role of toll-like receptors in systemic Candida albicans infections. Front Biosci (Landmark Ed). 2009;14:570-582.
42. Goodridge HS, Underhill DM. Fungal recognition by TLR2 and Dectin-1. Handb Exp Pharmacol. 2008;87-109.
43. Shah VB, Huang Y, Keshwara R, Ozment-Skelton T, Williams DL, Keshvara L. Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J Immunol. 2008;180:2777-2785.
44. Shah VB, Williams DL, Keshvara L. Beta-glucan attenuates TLR2-and TLR4-mediated cytokine production by microglia. Neurosci Lett. 2009;458:111-115.
45. Maneu V, Yanez A, Murciano C, Molina A, Gil ML, Gozalbo D. Dectin-1 mediates in vitro phagocytosis of Candida albicans yeast cells by retinal microglia. FEMS Immunol Med Microbiol. 2011;63:148-150.
46. Magrone T, Marzulli G, Jirillo E. Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. Curr Pharm Des. 2012;18:34-42.
47. Halder SK, Matsunaga H, Ishii KJ, Akira S, Miyake K, Ueda H. Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia. J Neurochem. 2013;126:243-260.
48. Tremblay S, Miloudi K, Chaychi S, et al. Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci. 2013;54:8125-8139.